Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › voriconazole

voriconazole

5 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of voriconazole

28 trials tracked of voriconazole: 15 in phase 3 or 4 and 4 with published results. The most-cited published study has 273 citations.

28Trials tracked
15Phase 3 & 4
0Recruiting
4With published results
Phase distribution
Phase 4 3 Phase 3 12 Phase 2 6 Phase 1 3 Other / NA 4
  1. Phase 3 A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069) Completed · 273 cited
  2. Phase 3 Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections Completed · 178 cited
  3. Phase 3 Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Completed · 39 cited
  4. Phase 3 The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo Completed
  5. Phase 4 To Determine The Amount Of Voriconazole In The Brain After 2 Loading Doses And 3 Maintenance Doses Over 3 Days Completed
  6. Phase 4 Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants Completed
Show 22 more trials
  1. Phase 4 This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis Completed
  2. Phase 3 Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101) Completed
  3. Phase 3 Voriconazole For Chronic Bronchopulmonary Aspergillosis Completed
  4. Phase 3 Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Completed
  5. Phase 3 Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis Completed
  6. Phase 3 Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis Completed
  7. Phase 3 Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis Completed
  8. Phase 3 Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study Completed
  9. Phase 3 Mycotic Ulcer Treatment Trial I Completed
  10. Phase 2 Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer Completed
  11. Phase 2 Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease Completed
  12. Phase 2 A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents Completed
  13. Phase 2 Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia Completed
  14. Phase 2 Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections Completed
  15. Phase 2 Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection Completed
  16. Phase 1 Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants Completed
  17. Phase 1 Drug-drug Interaction Trial of BI 113608 in Combination With Ketoconazole and Voriconazole in Healthy Male Subjects Completed
  18. Phase 1 Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies Completed
  19. N/A A Study Of Indian Patients Receiving Therapy For Systemic Fungal Infections Completed
  20. N/A Determine the Effects of Gene Differences and Voriconazole on Enzyme CYP2B6 Activity in the Liver in Healthy Volunteers Completed
  21. N/A Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan) Completed
  22. N/A Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan) Completed

Showing the 28 most-cited and recently-updated of 28 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Combination voriconazole and micafungin improved a boy with CGD and invasive Aspergillus lentulus infection
Rheumatology Guideline
Combination voriconazole and micafungin improved a boy with CGD and invasive Aspergillus lentulus infection Combination antifungals helped a boy with rare lung infection before transplant
This guideline discusses a case report of a boy with chronic granulomatous disease and invasive pulmonary Aspergillus lentulus infection. Th…
A boy with chronic granulomatous disease improved on two antifungal drugs before a pending stem cell transplant.
Frontiers Jun 2, 2026
Laboratory study evaluates antifungal susceptibility of Aspergillus from Costa Rican coffee beans
Primary Care & Family Medicine Guideline
Laboratory study evaluates antifungal susceptibility of Aspergillus from Costa Rican coffee beans Lab study finds coffee bean fungi often resist common antifungal drugs
This laboratory study evaluated antifungal susceptibility of Aspergillus spp. isolated from coffee beans in Costa Rica. The authors report m…
Laboratory testing of fungi from Costa Rican coffee beans shows many strains resist standard antifungal medications like amphotericin B and …
Frontiers May 20, 2026
Systematic review and meta-analysis shows antifungal resistance rates vary in diabetic foot ulcer patients
Diabetes & Endocrinology Meta-analysis
Systematic review and meta-analysis shows antifungal resistance rates vary in diabetic foot ulcer patients Antifungal resistance high in diabetic foot ulcers
This systematic review and meta-analysis evaluated antifungal resistance in patients with diabetic foot ulcers.
Many diabetic foot ulcer infections resist common antifungals, especially nystatin and itraconazole.
May 1, 2026
PPV and voriconazole for endogenous fungal endophthalmitis outbreak improves visual acuity
Infectious Disease Cohort
PPV and voriconazole for endogenous fungal endophthalmitis outbreak improves visual acuity Contaminated IVs Cause Sudden Blindness in Healthy Adults
This retrospective case series evaluated 26 eyes of 17 immunocompetent patients with endogenous fungal endophthalmitis following a rural cli…
Healthy adults lost vision after contaminated IV infusions, but early surgery and antifungals helped save sight in most cases.
Frontiers Apr 24, 2026
Prospective observational study on antifungal resistance in fungal keratitis in South India
Ophthalmology
Prospective observational study on antifungal resistance in fungal keratitis in South India Why Common Eye Infection Treatments Are Failing More Patients
This primary research article is a prospective observational study of 153 patients with fungal keratitis in South India.
Resistance to common eye drops is rising, making infections harder to cure.
medRxiv Apr 23, 2026